Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 493

1.

Comparative Effectiveness of Tocilizumab with either Methotrexate or Leflunomide in the Treatment of Rheumatoid Arthritis.

Narváez J, Díaz-Torné C, Magallares B, Hernández MV, Reina D, Corominas H, Sanmartí R, de la Serna AR, Llobet JM, Nolla JM.

PLoS One. 2015 Apr 1;10(4):e0123392. doi: 10.1371/journal.pone.0123392. eCollection 2015.

2.

Is non-biological treatment of rheumatoid arthritis as good as biologics?

Parida JR, Misra DP, Wakhlu A, Agarwal V.

World J Orthop. 2015 Mar 18;6(2):278-83. doi: 10.5312/wjo.v6.i2.278. eCollection 2015 Mar 18. Review.

3.

Pattern of drugs use and association with anti-mutated citrullinated vimentin antibody in rheumatoid arthritis.

Safi MA, Fathaldin OA.

Saudi Med J. 2015 Mar;36(3):316-23. doi: 10.15537/smj.2015.3.10208.

4.

The supplementary therapeutic DMARD role of low-dose glucocorticoids in rheumatoid arthritis.

Cutolo M, Spies CM, Buttgereit F, Paolino S, Pizzorni C.

Arthritis Res Ther. 2014 Nov 13;16 Suppl 2:S1. doi: 10.1186/ar4685.

5.

Pulmonary cryptococcosis that mimicked rheumatoid nodule in rheumatoid arthritis lesion.

Jang DW, Jeong I, Kim SJ, Kim SW, Park SY, Kwon YH, Jeong YO, Lee JY, Kim BS, Kim WS, Joh JS.

Tuberc Respir Dis (Seoul). 2014 Dec;77(6):266-70. doi: 10.4046/trd.2014.77.6.266. Epub 2014 Dec 31.

6.

Myelosuppressive and hepatotoxic potential of leflunomide and methotrexate combination in a rat model of rheumatoid arthritis.

Bilasy SE, Essawy SS, Mandour MF, Ali EA, Zaitone SA.

Pharmacol Rep. 2015 Feb;67(1):102-14. doi: 10.1016/j.pharep.2014.08.009. Epub 2014 Aug 23.

PMID:
25560583
7.

Elevated serum IgG4 defines specific clinical phenotype of rheumatoid arthritis.

Chen LF, Mo YQ, Ma JD, Luo L, Zheng DH, Dai L.

Mediators Inflamm. 2014;2014:635293. doi: 10.1155/2014/635293. Epub 2014 Dec 7.

8.

Relative efficiencies of the 7 rheumatoid arthritis Core Data Set measures to distinguish active from control treatments in 9 comparisons from clinical trials of 5 agents.

Pincus T, Richardson B, Strand V, Bergman MJ.

Clin Exp Rheumatol. 2014 Sep-Oct;32(5 Suppl 85):S-47-54. Epub 2014 Oct 30.

PMID:
25365089
9.

Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial.

Verschueren P, De Cock D, Corluy L, Joos R, Langenaken C, Taelman V, Raeman F, Ravelingien I, Vandevyvere K, Lenaerts J, Geens E, Geusens P, Vanhoof J, Durnez A, Remans J, Vander Cruyssen B, Van Essche E, Sileghem A, De Brabanter G, Joly J, Meyfroidt S, Van der Elst K, Westhovens R.

Ann Rheum Dis. 2015 Jan;74(1):27-34. doi: 10.1136/annrheumdis-2014-205489. Epub 2014 Oct 30.

PMID:
25359382
10.

[Acute interstitial pneumonia in patient with rheumatoid arthritis treated with leflunomide].

Siemion-Szcześniak I, Bartoszuk I, Bartosiewicz M, Jakubowska L, Wesołowski S, Kuś J.

Pneumonol Alergol Pol. 2014;82(6):568-75. doi: 10.5603/PiAP.2014.0075. Polish.

11.

Treatment of rheumatoid arthritis with methotrexate alone and in combination with other conventional DMARDs using the T2T strategy. A cohort study.

Santos-Moreno PI, de la Hoz-Valle J, Villarreal L, Palomino A, Sánchez G, Castro C.

Clin Rheumatol. 2015 Feb;34(2):215-20. doi: 10.1007/s10067-014-2794-9. Epub 2014 Oct 17.

PMID:
25318612
12.

Effect of combination therapy on joint destruction in rheumatoid arthritis: a network meta-analysis of randomized controlled trials.

Graudal N, Hubeck-Graudal T, Tarp S, Christensen R, Jürgens G.

PLoS One. 2014 Sep 22;9(9):e106408. doi: 10.1371/journal.pone.0106408. eCollection 2014.

13.

Association between serum uric acid and inflammation in rheumatoid arthritis: perspective on lowering serum uric acid of leflunomide.

Choe JY, Kim SK.

Clin Chim Acta. 2015 Jan 1;438:29-34. doi: 10.1016/j.cca.2014.07.039. Epub 2014 Aug 7.

PMID:
25108207
14.

Pigmented villonodular synovitis developing in a patient with rheumatoid arthritis.

Zhao X, Ji W, Qian X, Lu Y.

J Clin Rheumatol. 2014 Aug;20(5):283-6. doi: 10.1097/RHU.0000000000000119.

PMID:
25036563
15.

Recommendations of the French Society for Rheumatology for managing rheumatoid arthritis.

Gaujoux-Viala C, Gossec L, Cantagrel A, Dougados M, Fautrel B, Mariette X, Nataf H, Saraux A, Trope S, Combe B; French Society for Rheumatology.

Joint Bone Spine. 2014 Jul;81(4):287-97. doi: 10.1016/j.jbspin.2014.05.002. Epub 2014 Jun 27.

16.
17.

Use of oral and subcutaneous methotrexate in rheumatoid arthritis patients in the United States.

Curtis JR, Zhang J, Xie F, Beukelman T, Chen L, Fernandes J, Ginsberg S, Spettell C, Yun H, Saag KG, Schiff M.

Arthritis Care Res (Hoboken). 2014 Nov;66(11):1604-11. doi: 10.1002/acr.22383.

PMID:
24942466
18.

Short-term efficacy of etanercept plus methotrexate vs combinations of disease-modifying anti-rheumatic drugs with methotrexate in established rheumatoid arthritis.

Fleischmann R, Koenig AS, Szumski A, Nab HW, Marshall L, Bananis E.

Rheumatology (Oxford). 2014 Nov;53(11):1984-93. doi: 10.1093/rheumatology/keu235. Epub 2014 Jun 6.

PMID:
24907147
19.

Severe leukopenia in a rheumatoid arthritis patient treated with a methotrexate/leflunomide combination.

Toth P, Bernd R.

Rev Bras Reumatol. 2014 Mar-Apr;54(2):152-4. English, Portuguese.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk